Home
>
National Drug Code (NDC)
>
ZENPEP
ZENPEP - 42865-105-01 - (pancrelipase)
Drug Information of ZENPEP
| Product NDC: | 42865-105 |
| Proprietary Name: | ZENPEP |
| Non Proprietary Name: | pancrelipase |
| Active Ingredient(s): | 136000; 25000; 85000 [USP'U]/1; [USP'U]/1; [USP'U]/1 & nbsp; pancrelipase |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE, DELAYED RELEASE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of ZENPEP
| Product NDC: | 42865-105 |
| Labeler Name: | Aptalis Pharma US, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA022210 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20110719 |
Package Information of ZENPEP
| Package NDC: | 42865-105-01 |
| Package Description: | 12 CAPSULE, DELAYED RELEASE in 1 BOTTLE, GLASS (42865-105-01) |
NDC Information of ZENPEP
| NDC Code | 42865-105-01 |
| Proprietary Name | ZENPEP |
| Package Description | 12 CAPSULE, DELAYED RELEASE in 1 BOTTLE, GLASS (42865-105-01) |
| Product NDC | 42865-105 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | pancrelipase |
| Dosage Form Name | CAPSULE, DELAYED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20110719 |
| Marketing Category Name | NDA |
| Labeler Name | Aptalis Pharma US, Inc. |
| Substance Name | PANCRELIPASE AMYLASE; PANCRELIPASE LIPASE; PANCRELIPASE PROTEASE |
| Strength Number | 136000; 25000; 85000 |
| Strength Unit | [USP'U]/1; [USP'U]/1; [USP'U]/1 |
| Pharmaceutical Classes |
